Summary
Interest in genetic marker studies of schizophrenia has been considerably enhanced by the advent of recombinant DNA technology, which has dramatically increased the number of available markers. In the present paper, we review studies that have been carried out using classical markers as well as the more recent molecular studies. The problems that arise when schizophrenia is studied in this way are discussed and attempts are made to account for some of the conflicting findings in this area.
Similar content being viewed by others
References
Alexander RC, Coggiano M, Daniel DG, Wyatt RJ (1990) HLA antigen in schizophrenia. Psychiatry Res 31:221–233
Andrew B, Watt DC, Gillespie C, Chapel H (1987) A study of genetic linkage in schizophrenia. Psychol Med 17:363–370
Asaka A, Okazaki Y, Namura I, Juji T (1981) Study of HLA antigens among Japanese schizophrenics. Br J Psychiatry 138:498–500
Aschauer HN, Aschauer-Treiber G, Isenberg KE, Todd RD, Knesevich MA, Garner DL, Reich T, Cloninger CB (1990) No evidence for linkage between chromosome 5 markers and schizophrenia. Hum Hered 40:109–115
Baron M (1976) Albinism and schizophreniform psychosis: a pedigree study. Am J Psychiatry 133:1070–1073
Bassett A, McGillvray BC, Jones BD, Pantzar JT (1988) Partial trisomy chromosome 5 co-segregating with schizophrenia. Lancet I:799–801
Chadda R, Kullhara P, Singh T, Sehgal S (1986) HLA antigens in schizophrenia: a family study. Br J Psychiatry 149:612–615
Chamberlain S, Shaw J, Rowland A, et al (1988) Mapping of mutation causing Friedreich's ataxia to human chromosome 9. Nature 334:248–250
Collinge J, Boccio A, Delisi LE, Johnstone E, Lofthousen R, Owen F, Poulter M, Risby D, Shah T, Crow TJ (1989) Evidence for a pseudoautosomal locus for schizophrenia: a sibling pair analysis. Cytogenet Cell Genet 51:978
Crow TJ (1987) Pseudoautosomal locus for psychosis? Lancet II:1532
Crow TJ (1988) Sex chromosomes and psychosis: the case for a pseudoautosomal locus. Br J Psychiatry 153:675–683
Crow TJ, Delisi LE, Johnstone EC (1989) Concordance by sex in sibling pairs with schizhophrenia is paternally inherited: evidence for a pseudoautosomal locus. Br J Psychiatry 155:92–97
Crowe RR, Thompson IS, Flink RF, Weinberger B (1979) HLA antigens and schizophrenia. Arch Gen Psychiatry 36:231–233
Detera-Wadleigh SD, Goldin LR, Sherrington R, Encio I, de Miguel E, Barrettini W, Gurling H (1989) Exclusion of linkage to 5q11–13 in families with schizophrenia and other psychiatric disorders. Nature 340:391–392
Diehl S, Su Y, Aman M, Machean C, Walsh D, O'Hare A, McGulte M, Kidd K, Kendler K (1989) Paper presented at the First World Congress on Psychiatric. Genetics, Cambridge
Eberhard G, Franzen G, Low B (1975) Schizophrenia susceptibility and HLA antigens. Neuropsychobiology 1:211–217
Elston RC, Kringlen E, Namboodri KK (1973) Possible linkage relationship between certain blood groups and schizophrenia or other psychoses. Behav Genet 3:101–106
Goate AM, Haynes AR, Owen MJ, Farrell M, James LA, Lai LYC, Mullan MT, Roques P, Rosser MN, Williamson R, Hardy JA (1989) Predisposing locus for Alzheimer's Disease on chromosome 21. Lancet I:355–359
Goldin LR, De Lisi LF, Gershon ES (1987) The relationship of HLA to schizophrenia in 10 nuclear families. Psychiatry Res 20:69–78
Grandy KD, Litt M, Allen N, Bunzow JR, Marchionni M, Makam H, Reed L, Magenis RE, Civelli O (1989) The human dopamine D2 receptor gene is located on chromosome 11 at q22–23 and identifies a Taq 1 RFLP. Am J Hum Genet 45:778–785
Gurling H (1990) Review. Transmission 9:15
Holland T, Gosden C (1990) A balanced chromosomal translocation partially co-segregating with psychotic illness in a family. Psychiatry Res 32:1–8
Human Gene Mapping 10 (1989) Tenth International Workshop on Human Gene Mapping. Cytogenet Cell Genet 51:1–1148
Ivanyi D, Zemek P, Ivanyi P (1978) HLA antigens as possible markers of heterogeneity in schizophrenia. J Immunogenet 5:165–172
Ivanyi P, Droes J, Schreuder GMT, D'Amaro J, van Rood JJ (1983) A search for association of HLA antigens with paranoid schizophrenia. Tissue Antigens 22:186–193
Julien RA, Mercier P, Choaraqui IP, Sutter TM (1978) Schizophrenes et antigenes d'histocompatibilite. Encephale IV:99–113
Kendler KS (1987) The feasibility of linkage studies in schizophrenia. In: Helmchen H, Henn FA (eds) Biological perspectives of schizophrenia. John Wiley, Chichester
Kennedy JL, Giuffra LA, Moises HW, Cavalli-Sforza LL, Pakstis AJ, Kidd JR, Castiglione CM, Sjogren B, Wetterberg L, Kidd KK (1988) Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree. Nature 336:167–170
Lander ES (1988) Splitting schizophrenia. Nature 336:105–106
Leboyer M, Malafosse A, Boularand S, Campion D, Gheysen F, Somolyk D, Henriksson B, Denise E, des Lauriers A, Lepine JP, Zarfian E, Clerget-Darpeux F, Mallet J (1990) Tyrosine hydroxylase polymorphisms associated with manic-depressive illness. Lancet 335:1219
Propert DN (1983) Immunoglobulin allotypes Gm and Km in chronic schizophrenia: no apparent association. Psychol Med 13:27–30
McGue M, Gottesman II, Rao DC (1985) Resolving genetic models for the transmission of schizophrenia. Genet Epidemiol 2:99–110
McGuffin P, Farmer AE, Rajah SM (1978) Histocompatibility antigens and schizophrenia. Br J Psychiatry 132:149–151
McGuffin P, Farmer AE, Yonase A (1981) HLA antigens and subtypes of schizophrenia. Psychiatry Res 5:115–122
McGuffin P, Festenstein H, Murray RM (1983) A family study of HLA antigens and other genetic markers in schizophrenia. Psychol Med 13:31–43
McGuffin P, Sturt E (1986) Genetic markers in schizophrenia. Hum Hered 36:65–88
McGuffin P (1988) Genetics of schizophrenia. In: Bebbington P, McGuffin P (eds) Schizophrenia: the major issues. Heinemann Medical. London, pp 107–126
McGuffin P, Sargeant M, Hett G, Tidmarsh S, Whatley S, Marchbanks RM (1990) Exclusion of a schizophrenia susceptibility gene from the chromosome 5q11–q13 region. New data and a re-analysis of previous reports. Am J Hum Genet 47:524–535
Miyanga K, Machiymaya Y, Juji T (1984) Schizophrenic disorders and HLA-DR antigens. Biol Psychiatry 19:121–129
Moises HW, Gelernter J, Grandy DK, Giuffra LA, Kidd JR, Pakstis AJ, Bunzow J, Sjogren B, Wetterberg L, Kennedy JL, Litt M, Civelli O, Kidd KK, Cavalli-Sforza LL (1989) Exclusion of the D2-dopamine receptor gene as candidate gene for schizophrenia in a large pedigree from Sweden. Paper in First World Congress on Psychiatric Genetics, Cambridge
Monaco AP, Bertelson CJ, Middlesworth W, Colletti CA (1985) Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature 316:842–845
Monaco AP, Neve RL, Colletti-Feeno C, Bertelson CJ, Kurnit D, Kunkel LM (1986) Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323:646–650
Morton NE (1955) Sequential tests for the detection of linkage. Am J Hum Genet 7:277–318
Morton NE (1982) Outline of genetic epidemiology. Karger, Basel
Mourant AE, Kopec AC, Domaniewska-Sobczak K (1975) Blood groups and diseases. Oxford University Press, Oxford
Naguib M, McGuffin P, Levy R, Festenstein H, Alonzo A (1987) Genetic markers in late paraphrenia. Br J Psychiatry 150:124–127
O'Rourke DH, Gottesman II, Suarez BK, Rice J, Reiche T (1982) Refutation of the single locus model in the aetiology of schizophrenia. Am J Hum Genet 33:630–649
Rinieris P, Stefanis C, Lykouras E, Varson E (1982) Subtypes of schizophrenia and ABO blood types. Neuropsychobiology 9:57–59
Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelezak Z, Zielenski J, Lok S, Plavsic N, Chou J, Drumm ML, Iannuzzi MC, Collins FS, Tsui L (1989) Identification of the cystic fibrosis gene: cloning and characterization of complimentary DNA. Science 245:1066–1073
Rudduck C (1985) Genetic markers and schizophrenia. PhD Thesis, University of Lund, Lund, Sweden
Sampson JR, Yates JRW, Pirrit LA, Fleury P (1989) Evidence for genetic heterogeneity in tuberous sclerosis. J Med Genet 26:511–516
St. Clair D, Blackwood D, Muir W, Baillie D, Hubbard S, Wright A, Evans HJ (1989) No linkage of chromosome 5q11–q13 markers to schizophrenia in Scottish families. Nature 339:305–309
St. George-Hyslop P, Tanzi RE, Polinsky RJ, Haines JL, Ree L, Watkins PC, Myers RH, Feldman RG, Pollen D, Drachman D, Growdon J, Bruni A, Foncin J-F, Salmon D, Frommelt P, Amaducci L, Sorbi S, Piacentini S, Stewart GD, Hobbs WJ, Conneally M, Gusella JF (1987) The genetic defect causing familial Alzheimer's Disease maps on chromosome 21. Science 235:885–890
Sherrington R, Brynjolfsson J, Petursson H, Potter M, Dudleston K, Barraclough B, Wasmuth J, Dobbs M, Gurling H (1988) Localization of susceptibility locus for schizophrenia on chromosome 5. Nature 336:164–167
Smith M, Wasmuth J, MePherson JD, Wagner C, Grandy D, Civelli O, Potkin S, Litt M (1989) Cosegregation of an 11q22 3–9 p22 translocation with affective disorder: proximity of the dopamine D2 receptor gene relative to the translocation breakpoint. Am J Hum Genet 45:A220
Sturt E, McGuffin P (1985) Can linkage and marker association resolve the genetic aetiology of psychiatric disorders: Review and argument (editorial). Psychol Med 15:455–462
Turner WJ (1979) Genetic markers for schizophrenia. Biol Psychiatr 14:177–205
Whatley SA, Owen MJ (1989) Molecular genetics and its application to the study of psychiatric disorders. Int Rev Psychiatry 1:219–230
Woolf B (1955) On estimating the relation between blood groups and disease. Ann Hum Genet 19:251–253
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Owen, M.J., McGuffin, P. DNA-and classical genetic markers in schizophrenia. Eur Arch Psychiatry Clin Nuerosci 240, 197–203 (1991). https://doi.org/10.1007/BF02190764
Issue Date:
DOI: https://doi.org/10.1007/BF02190764